Detalhe da pesquisa
1.
The landscape of alterations affecting epigenetic regulators in T-cell acute lymphoblastic leukemia: Roles in leukemogenesis and therapeutic opportunities.
Int J Cancer;
154(9): 1522-1536, 2024 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38155420
2.
Targeting hyperactive platelet-derived growth factor receptor-ß signaling in T-cell acute lymphoblastic leukemia and lymphoma.
Haematologica;
2023 Nov 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37941480
3.
Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia.
Blood;
134(16): 1323-1336, 2019 10 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31492675
4.
Evaluating nuclear translocation of surface receptors: recommendations arising from analysis of CD44.
Histochem Cell Biol;
153(2): 77-87, 2020 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31834485
5.
Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL.
Blood;
131(4): 421-425, 2018 01 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29187379
6.
Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice.
Eur J Immunol;
48(10): 1728-1738, 2018 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30025160
7.
FAT1 cadherin controls neuritogenesis during NTera2 cell differentiation.
Biochem Biophys Res Commun;
514(3): 625-631, 2019 06 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31076104
8.
BETter insight into PRC2-mutated T-ALL.
Blood;
138(19): 1787-1788, 2021 11 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34762130
9.
Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors.
Blood;
128(23): 2642-2654, 2016 12 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27694322
10.
Cell biology: A mitochondrial brake on vascular repair.
Nature;
539(7630): 503-505, 2016 11 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27828945
11.
JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model.
Blood;
124(20): 3092-100, 2014 Nov 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25193870
12.
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia.
Blood;
124(25): 3738-47, 2014 Dec 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25301704
13.
FAT1 cadherin acts upstream of Hippo signalling through TAZ to regulate neuronal differentiation.
Cell Mol Life Sci;
72(23): 4653-69, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26104008
14.
Furin processing dictates ectodomain shedding of human FAT1 cadherin.
Exp Cell Res;
323(1): 41-55, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24560745
15.
Sleeping giants: emerging roles for the fat cadherins in health and disease.
Med Res Rev;
34(1): 190-221, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23720094
16.
T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.
Haematologica;
104(5): e204-e207, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30514801
17.
Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.
BMC Cancer;
14: 630, 2014 Aug 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25168062
18.
In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenografts.
Exp Hematol;
132: 104176, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38320689
19.
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.
J Clin Invest;
134(6)2024 Feb 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38319732
20.
A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing.
Haematologica;
103(12): e585-e589, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29954933